2-Acetylaminofluorene mechanistic data and risk assessment: DNA reactivity, enhanced cell proliferation and tumor initiation

Pharmacology and Therapeutics

Volumn 71, Issue 1-2, 1996, Pages 83-105

  Verna, Lynne ^a   Whysner, John ^a   Williams, Gary M ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

2 acetylaminofluorene; aromatic amines; DNA adducts; genotoxicity; neoplasia; risk assessment

Indexed keywords

N (2 FLUORENYL)ACETAMIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; BLADDER CANCER; CANCER RISK; CARCINOGENICITY; CELL PROLIFERATION; DNA ADDUCT; DOSE RESPONSE; GENOTOXICITY; LIVER CANCER; METABOLIC ACTIVATION; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; REVIEW; RISK ASSESSMENT;

EID: 0029746045     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/0163-7258(96)00063-0     Document Type: Review

References (107)

1. Alvi, N. K. and Williams, G. M. (1992) Restriction fragment pattern analysis of HPRT mutations induced in rat liver epithelial cells by alkylating and arylating agents. Mutat. Res. 265: 283-295.
2. Amacher, D. E. and Turner, G. N. (1989) The critical influence of temperature upon trifluorothymidine resistance in mouse lymphoma L5178Y/TK 3.7.2C cells. Mutat. Res. 224: 415-426.
3. Ames, B. N., Gurney, E. G., Miller, J. A. and Bartsch, H. (1972) Carcinogens as frameshift mutagens: metabolites and derivatives of 2-acetylaminofluorene and other aromatic amine carcinogens. Proc. Natl. Acad. Sci. USA 69: 3128-3132.
4. Ames, B. N., Durston, W. E., Yamasaki, E. and Lee, F. D. (1973) Carcinogens are mutagens: a simple test system combining liver homogenates for activation and bacteria for detection. Proc. Natl. Acad. Sci. USA 70: 2281-2285.
5. 32P-postlabeling method in quantitative DNA adduct dosimetry of 2-acetylaminofluorene-induced mutagenicity in Chinese hamster ovary cells and Salmonella typhimurium TA 1538. Carcinogenesis 8: 515-520.
6. Ashby, J., Lefevre, P. A., Burlinson, B. and Beije, B. (1986) Potent mitogenic activity of 4-acetylaminofluorene to the rat liver. Mutat. Res. 172: 271-279.
7. 32P-postlabelling of DNA and the autoradiographic UDS assay in the liver of mice exposed to 2-acetylaminofluorene (2AAF). Mutat. Res. 252: 259-268.
8. Barratt, R. W. and Tatum, E. L. (1951) An evaluation of some carcinogens as mutagens. Cancer Res. 11: 234.
9. Beland, F. A., Fullerton, N. F., Kinouchi, T. and Poirier, M. C. (1988) DNA adduct formation during continuous feeding of 2-acetylaminofluorene at multiple concentrations. IARC Sci. Publ. 89: 175-180.
10. Burnouf, D., Koehl, P. and Fuchs, R. P. P. (1989) Single adduct mutagenesis: strong effect of the position of a single acetylaminofluorene adduct within a mutation hot spot. Proc. Natl. Acad. Sci. USA 86: 4147-4151.
11. Carothers, A. M., Urlaub, G., Steigerwalt, R. W., Chasin, L. A. and Grunberger, D. (1986) Characterization of mutations induced by 2-(N-acetyl)aminofluorene in the dihydrofolate reductase gene of cultured hamster cells. Proc. Natl. Acad. Sci. USA 83: 6519-6523.
12. Carothers, A. M., Urlaub, G., Steigerwalt, R. W., Chasin, L. A. and Grunberger, D. (1988) Spectrum of N-2-acetylaminofluorene-induced mutations in the dihydrofolate reductase gene of Chinese hamster ovary cells. In: Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes, pp. 337-349, King, C. M., Romano, L. J. and Schuetzle, D. (eds.) Elsevier, White Plains.
13. Cassand, P., Leveque, F., Decoudu, S. and Narbonne, J. F. (1990) Relationship between vitamin A dietary intake and mutagenic activity of some chemical carcinogens. Food Addit. Contam. 7: S58-S59.
14. 01 study. Toxicol. Appl. Pharmacol. 104: 79-93.
15. Connor, T. H., Ramanujam, V. M. S., Rinkus, S. J., Legator, S. and Trieff, N. M. (1983) The evaluation of mutagenicities of 19 structurally related aromatic amines and acetamides in Salmonella typhimurium TA98 and TA100. Mutat. Res. 118: 49-59.
16. Demerec, M., Wallace, B., Witkin, E. M. and Bertani, G. (1949) The gene. Carnegie Institution of Washington Yearbook 48: 154-166.
17. Durston, W. E. and Ames, B. N. (1974) A simple method for the detection of mutagens in urine: studies with the carcinogen 2-acetylaminofluorene. Proc. Natl. Acad. Sci. USA 71: 737-741.
18. Fahmy, O. G. and Fahmy, M. J. (1970) Gene elimination in carcinogenesis: reinterpretation of the somatic mutation theory. Cancer Res. 30: 195-205.
19. Fahmy, O. G. and Fahmy, M. J. (1972) Mutagenic properties of N-acetyl-2-aminofluorene and its metabolites in relation to the molecular mechanisms of carcinogenesis. Int. J. Cancer 9: 284-298.
20. Farber, E. and Cameron, R. (1980) The sequential analysis of cancer development. Adv. Cancer Res. 31: 125-226.
21. Farmer, J. H., Kodell, R. L. and Greenman, D. L. (1979) Dose and time response models for the incidence of bladder and liver neoplasms in mice fed 2-acetylaminofluorene continuously. J. Environ. Pathol. Toxicol. 3: 55-68.
22. Felton, J. S. and Nebert, D. W. (1975) Mutagenesis of certain activated carcinogens in vitro associated with genetically mediated increases in monooxygenase activity and cytochrome P-450. J. Biol. Chem. 250: 6769-6778.
23. Frederick, C. B., Dooley, K. L., Kodell, R. L., Sheldon, W. G. and Kadlubar, F. F. (1989) The effect of lifetime sodium saccharin dosing on mice initiated with the carcinogen 2-acetylaminofluorene. Fundam. Appl. Toxicol. 12: 346-357.
24. 01 Study), pp. 103-119, Staffa, J. A. and Mehlman, M. A. (eds.) Pathotox, Park Forest South.
25. 01 Study), pp. 121-138, Staffa, J. A. and Mehlman, M. A. (eds.) Pathotox, Park Forest South.
26. Fuchs, R. P. P., Bichara, M. and Koffel-Schwartz, N. (1988) Molecular mechanisms involved in mutagenesis induced by N-2-aminofluorene derivatives. In: Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes, pp. 373-384, King, C. M., Romano, L. J. and Schuetzle, D. (eds.) Elsevier, White Plains.
27. 1 mice fed AIN-76A diet versus NIH-07 diet. Fundam. Appl. Toxicol. 16: 51-60.
28. 32P-postlabelling of DNA and the autoradiographic UDS assay in the liver of rats exposed to 2-acetylaminofluorene (2AAF). Mutat. Res. 252: 247-257.
29. Goldstein, J. A., Weaver, R. and Sundheimer, D. W. (1984) Metabolism of 2-acetylaminofluorene by two 3-methylcholanthrene-inducible forms of rat liver cytochrome P-450. Cancer Res. 44: 3768-3771.
30. Gonzalez, F. J. (1989) The molecular biology of cytochrome P450s. Pharmacol. Rev. 40: 243-288.
31. Green, M. H. L. (1980) The scientific basis for short-term tests for carcinogenicity: non-mammalian systems. In: Molecular and Cellular Aspects of Carcinogen Screening Tests, pp. 155-167, Montesano, R., Bartsch, H. and Tomatis, L. (eds.) International Agency for Research on Cancer, Lyon.
32. Gupta, R. C., Earley, K. and Becker, F. F. (1988) Analysis of DNA adducts in putative premalignant hepatic nodules and nontarget tissues of rats during 2-acetylaminofluorene carcinogenesis. Cancer Res. 48: 5270-5274.
33. Heflich, R. H., Djuric, Z., Zhou, Z., Fullerton, N. F., Casciano, D. A. and Beland, F. A. (1988) Metabolism of 2-acetylaminofluorene in the Chinese hamster ovary cell mutation assay. Environ. Mol. Mutagen. 11: 167-181.
34. Hingerty, B. E. and Broyde, S. (1986) Energy minimized structures of carcinogen-DNA adducts: 2-acetylaminofluorene and 2-aminofluorene. J. Biomol. Struct. Dyn. 4: 365-372.
35. Huitfeldt, H. S., Brandtzaeg, P. and Poirier, M. C. (1990) Reduced DNA adduct formation in replicating liver cells during continuous feeding of a chemical carcinogen. Proc. Natl. Acad. Sci. USA 87: 5955-5958.
36. Huitfeldt, H. S., Brandtzaeg, P. and Poirier, M. C. (1991) Carcinogen-induced alterations in rat liver DNA adduct formation determined by computerized fluorescent image analysis. Lab. Invest. 64:207-214.
37. Johnson, E. F., Levitt, D. S., Muller-Eberhard, U. and Thorgeirsson, S. S. (1980) Catalysis of divergent pathways of 2-acetylaminofluorene metabolism by multiple forms of cytochrome P-450. Cancer Res. 40: 4456-4459.
38. Kadlubar, F. F., Butler, M. A., Kaderlik, K. R., Chou, H. C. and Lang, N. P. (1992) Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ. Health Perspect. 98: 69-74.
39. Katayama, S., Ohmori, T., Maeura, Y., Croci, T. and Williams, G. M. (1984) Early stages of N-2-fluorenylacetamide-induced hepatocarcinogenesis in male and female rats and effect of gonadectomy on liver neoplastic conversion and neoplastic development. J. Natl. Cancer Inst. 73: 141-149.
40. Klohn, P. C., Massalha, H. and Neumann, H. G. (1995) A metabolite of carcinogenic 2-acetylaminofluorene, 2-nitrosofluorene, induces redox cycling in mitochondria. Biochim. Biophys. Acta 1229: 163-372.
41. 1 from Aspergillus oryzae. Cancer Lett. 7: 147-154.
42. Kroese, E. D., van de Poll, M. L. M., Mulder, G. J. and Meerman, J. H. N. (1988) The role of N-sulfation in the N-hydroxy-2-acetylaminofluorene-mediated outgrowth of diethylnitrosamine-initiated hepatocytes to γ-glutamyltranspeptidase-positive foci in male rat liver. Carcinogenesis 9: 1953-1958.
43. Langenbach, R. and Rudo, K. (1988) Human hepatocyte and kidney cell metabolism of 2-acetylaminofluorene and comparison to the respective rat cells. Cell Biol. Toxicol. 4: 453-465.
44. Langenbach, R., Rudo, K., Ellis, S., Hix, C. and Nesnow, S. (1987) Species variation in bladder cell and liver cell activation of acetylaminofluorene. Cell Biol. Toxicol. 3: 303-319.
45. 1 mouse hepatocytes in vitro. Cell Biol. Toxicol. 6: 15-21.
46. Littlefield, N. A., Farmer, J. H. and Gaylor, D. W. (1979a) Effects of dose and time in a long-term, low-dose carcinogenic study. J. Environ. Pathol. Toxicol. 3: 17-34.
47. 01 Study), pp. 35-53, Staffa, J. A. and Mehlman, M. A. (eds.) Pathotox, Park Forest South.
48. Lotlikar, P. D., Fukuda, S. and Yamamoto, N. (1972) Effects of the carcinogen 2-acetylaminofluorene and its derivatives on bacteria and bacteriophages. Mol. Pharmacol. 8:645-650.
49. Maeura, Y. and Williams, G. M. (1984) Enhancing effect of butylated hydroxytoluene on the development of liver altered foci and neoplasms induced by N-2-fluorenylacetamide in rats. Food Chem. Toxicol. 22: 191-198.
50. Maeura, Y., Weisburger, J. H. and Williams, G. M. (1984) Dose-dependent reduction of N-2-fluorenylacetamide-induced liver cancer and enhancement of bladder cancer in rats by butylated hydroxytoluene. Cancer Res. 44: 1604-1610.
51. Mah, C. M., Maher, V. M., Thomas, H., Reid, T. M., King, C. M. and McCormick, J. J. (1989) Mutations induced by aminofluorene-DNA adducts during replication in human cells. Carcinogenesis 10: 2321-2328.
52. McCann, J. and Ames, B. N. (1977) The Salmonella/microsome mutagenicity test: predictive value for animal carcinogenicity. In: Origins of Human Cancer, pp. 1431-1450, Hiatt, H. H., Watson, J. D. and Winsten, J. A. (eds.) Cold Spring Harbor Laboratory, Cold Spring Harbor.
53. McCann, J., Choi, E., Yamasaki, E. and Ames, B. N. (1975) Detection of carcinogens as mutagens in the Salmonella/ microsome test: assay of 300 chemicals. Proc. Natl. Acad. Sci. USA 72: 5135-5139.
54. McGregor, D. (1975) The relationship of 2-acetamidofluorene mutagenicity in plate tests with its in vivo liver cell component distribution and its carcinogenic potential. Mutat. Res. 30: 305-316.
55. McManus, M. E., Minchin, R. F., Sanderson, N., Schwartz, D., Johnson, E. F. and Thorgeirsson, S. S. (1984) Metabolic processing of 2-acetylaminofluorene by microsomes and six highly purified cytochrome P-450 forms from rabbit liver. Carcinogenesis 5: 1717-1723.
56. McManus, M. E., Burgess, W. M., Veronese, M. E., Huggett, A., Quattrochi, L. C. and Tukey, R. H. (1990) Metabolism of 2-acetylaminofluorene and benzo(a)pyrene and activation of food-derived heterocyclic amine mutagens by human cytochromes P-450. Cancer Res. 50: 3365-3376.
57. McQueen, C. A. and Williams, G. M. (1983) The use of cells from rat, mouse, hamster, and rabbit in the hepatocyte primary culture/DNA-repair test. Ann. NY Acad. Sci. 407: 119-130.
58. McQueen, C. A., Miller, M. J. and Williams, G. M. (1986) Sex-differences in the biotransformation of 2-acetylaminofluorene in cultured rat hepatocytes. Cell Biol. Toxicol. 2: 271-281.
59. McQueen, C. A., Way, B. M. and Williams, G. M. (1987) Biotransformation of aromatic amines to DNA-damaging products by urinary bladder organ cultures. Carcinogenesis 8: 401-404.
60. Miller, E. C. and Miller, J. A. (1981) Searches for ultimate chemical carcinogens and their reactions with cellular macromolecules. Cancer 47: 2327-2345.
61. Miller, E. C., Miller, J. A. and Hartmann, H. A. (1961) N-hydroxy-2-acetylaminofluorene with increased carcinogenic activity in the rat. Cancer Res. 21: 815-824.
62. Miller, E. C., Miller, J. A. and Enomoto, M. (1964) The comparative carcinogenicities of 2-acetylaminofluorene and its N-hydroxy metabolite in mice, hamsters and guinea pigs. Cancer Res. 24: 2018-2031.
63. Møller, M. E., Glowinski, I. B. and Thorgeirsson, S. S. (1984) The genotoxicity of aromatic amines in primary hepatocytes isolated from C57BL/6 and DBA/2 mice. Carcinogenesis 5: 797-804.
64. Mori, H., Tanaka, T., Sugie, S., Takahashi, M. and Williams, G. M. (1982) DNA content of liver cell nuclei of N-2-fluorenylacetamide-induced altered foci and neoplasms in rats and human hyperplastic foci. J. Natl. Cancer Inst. 69: 1277-1282.
65. Nakanishi, K., Fukushima, S., Hagiwara, A., Tamano, S. and Ito, N. (1982) Organ-specific promoting effects of phenobarbital sodium and sodium saccharin in the induction of liver and urinary bladder tumors in male F344 rats. J. Natl. Cancer Inst. 68: 497-500.
66. National Research Council (1993) Issues in Risk Assessment. National Academy Press, Washington, DC.
67. Okinaka, R. T., Whaley, T. W. and Strniste, G. F. (1988) Differential effects induced by N-hydroxy-2-acetylaminofluorene and N-hydroxy-2-aminofluorene in DNA excision-repair-deficient Chinese hamster cells. Mutat. Res. 209: 45-50.
68. Peraino, C., Fry, R. J. M. and Staffeldt, E. (1971) Reduction and enhancement by phenobarbital of hepatocarcinogenesis induced in the rat by 2-acetylaminofluorene. Cancer Res. 31: 1506-1512.
69. Peraino, C., Fry, R. J. M., Staffeldt, E. and Kisieleski, W. E. (1973) Effects of varying the exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis in the rat. Cancer Res. 33: 2701-2705.
70. Peraino, C., Fry, R. J. M. and Staffeldt, E. (1977) Effects of varying the onset and duration of exposure to phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Cancer Res. 37: 3623-3627.
71. Peraino, C., Staffeldt, E. F., Haugen, D. A., Lombard, L. S., Stevens, F. J. and Fry, R. J. M. (1980) Effects of varying the dietary concentration of phenobarbital on its enhancement of 2-acetylaminofluorene-induced hepatic tumorigenesis. Cancer Res. 40: 3268-3273.
72. Poirier, M. C., Fullerton, N. F. and Beland, F. A. (1988) DNA adduct formation and removal during chronic dietary administration of 2-acetylaminofluorene. In: Carcinogenic and Mutagenic Responses to Aromatic Amines and Nitroarenes, pp. 321-328, King, C. M., Romano, L. J. and Schuetzle, D. (eds.) Elsevier, New York.
73. Poirier, M. C., Fullerton, N. F., Kinouchi, T., Smith, B. A. and Beland, F. A. (1991) Comparison between DNA adduct formation and tumorigenesis in livers and bladders of mice chronically fed 2-acetylaminofluorene. Carcinogenesis 12: 895-900.
74. Price, K. E., Buck, R. E. and Lein, J. (1964) Incidence of antineoplastic activity among antibiotics found to be inducers of lysogenic bacteria. Antimicrob. Agents Chemother. 505-517.
75. Robertson, E. G. C. (1986) The importance of 2-aminofluorene in the mutagenic activation of 2-acetylaminofluorene. Mutat. Res. 175: 153-157.
76. Romano, L. J., Johnson, D. L., Gupta, P. K., Reid, T. M., Lee, M. S. and King, C. M. (1988) Arylamine-induced mutagenesis by DNA adducts positioned at specific sites. In: Carcinogenic and Mutagenic Responses to Aromatic Amine and Nitroarenes, pp. 389-396, King, C. M., Romano, L. J. and Schuetzle, D. (eds.) Elsevier, Amsterdam.
77. Rosenkranz, H. S. and Poirier, L. A. (1979) Evaluation of the mutagenicity and DNA-modifying activity of carcinogens and noncarcinogens in microbial systems. J. Natl. Cancer Inst. 62: 873-891.
78. Rudo, K., Meyers, W. C., Dauterman, W. and Langenbach, R. (1987) Comparison of human and rat hepatocyte metabolism and mutagenic activation of 2-acetylaminofluorene. Cancer Res. 47: 5861-5867.
79. Saeter, G., Schwarze, P. E., Nesland, J. M. and Seglen, P. O. (1988) 2-Acetylaminofluorene promotion of liver carcinogenesis by a non-cytotoxic mechanism. Carcinogenesis 9: 581-587.
80. Schut, H. A. J., Daniel, F. B., Schenck, K. M., Loeb, T. R. and Stoner, G. D. (1984) Metabolism and DNA adduct formation of 2-acetylaminofluorene by bladder explants from human, dog, monkey, hamster and rat. Carcinogenesis 5: 1287-1292.
81. Scribner, J. D., Fisk, S. R. and Scribner, N. K. (1979) Mechanisms of action of carcinogenic aromatic amines: an investigation using mutagenesis in bacteria. Chem. Biol. Interact. 26: 11-25.
82. Shaw, C. R., Stout, D. L. and Baptist, J. N. (1975) Enzymes involved in mutagen formation from 2-acetylaminofluorene. Proc. Am. Assoc. Cancer Res. 16: 199.
83. Shirai, T., Tsuda, H., Ogiso, T., Hirose, M. and Ito, N. (1987) Organ specific modifying potential of ethinyl estradiol on carcinogenesis initiated with different carcinogens. Carcinogenesis 8: 115-119.
84. Sina, J. F., Bean, C. L., Dysart, G. R., Taylor, V. I. and Bradley, M. O. (1983) Evaluation of the alkaline elution/rat hepatocyte assay as a predictor of carcinogenic/mutagenic potential. Mutat. Res. 113: 357-391.
85. Smith, A. J. and Chipman, J. K. (1988) Inter-individual variation in the mutagenic activation of 2-acetylaminofluorene by human liver in relation to animal metabolic models. Mutagenesis 3: 323-328.
86. Solt, D. and Farber, E. (1976) New principle for the analysis of chemical carcinogenesis. Nature 263: 701-703.
87. Stout, D. L., Baptist, J. N., Matney, T. S. and Shaw, C. R. (1976) N-Hydroxy-2-aminofluorene: the principal mutagen produced from N-hydroxy-2-acetylaminofluorene by a mammalian supernatant enzyme preparation. Cancer Lett. 1: 269-274.
88. Sugai, M., Witting, L. A., Tsuchiyama, H. and Kummerow, F. A. (1962) The effect of heated fat on the carcinogenic activity of 2-acetylaminofluorene. Cancer Res. 22: 510-519.
89. Sugiyama, C., Kobayashi, H. and Kishi, M. (1989) Micronucleus test with 2-acetylaminofluorene by intraperitoneal injection and oral administration. Mutat. Res. 223: 361-364.
90. Tiwawech, D., Hasegawa, R., Kurata, Y., Tatematsu, M., Shibata, M. A., Thamavit, W. and Ito, N. (1991) Dose-dependent effects of 2-acetylaminofluorene on hepatic foci development and cell proliferation in rats. Carcinogenesis 12: 985-990.
91. Umemura, T., Tokumo, K., Sirma, H., Gebhardt, R., Poirier, M. C. and Williams, G. M. (1993) Dose response effects of 2-acetylaminofluorene on DNA damage, cytotoxicity, cell proliferation and neoplastic conversion in rat liver. Cancer Lett. 73: 1-10.
92. van de Poll, M. L. M., van der Hulst, D. A. M., Tates, A. D., Mulder, G. J. and Meerman, H. N. (1989) The role of specific DNA adducts in the induction of micronuclei by N-hydroxy-2-acetylaminofluorene in rat liver in vivo. Carcinogenesis 10: 717-722.
93. Vousden, K. H., Bos, J. L., Marshall, C. J. and Phillips, D. H. (1986) Mutations activating human c-Ha-ras1 protooncogene (HRAS1) induced by chemical carcinogens and depurination. Proc. Natl. Acad. Sci. USA 83: 1222-1226.
94. Watanabe, K. and Williams, G. M. (1978) Enhancement of rat hepatocellular-altered foci by the liver tumor promoter phenobarbital: evidence that foci are precursors of neoplasms and that the promoter acts on carcinogen-induced lesions. J. Natl. Cancer Inst. 61: 1311-1314.
95. Weisburger, E. K. and Weisburger, J. H. (1958) Chemistry, carcinogenicity and metabolism of 2-fluorenamine and related compounds. Adv. Cancer Res. 5: 331-431.
96. Wheeler, L. A., Carter, J. H., Soderberg, F. B. and Goldman, P. (1975) Association of Salmonella mutants with germfree rats: site specific model to detect carcinogens as mutagens. Proc. Natl. Acad. Sci. USA 72: 4607-4611.
97. Willems, M. I., de Raat, W. K., Baan, R. A., Wilmer, J. W. G. M., Lansbergen, M. J. and Lohman, P. H. M. (1987) Monitoring the exposure of rats to 2-acetylaminofluorene by the estimation of mutagenic activity in excreta, sister-chromatid exchanges in peripheral blood cells and DNA adducts in peripheral blood, liver and spleen. Mutat. Res. 176: 211-223.
98. Williams, G. M. (1976) Carcinogen-induced DNA repair in primary rat liver cell cultures; a possible screen for chemical carcinogens. Cancer Lett. 1: 231-236.
99. Williams, G. M. (1977) Detection of chemical carcinogens by unscheduled DNA synthesis in rat liver primary cell cultures. Cancer Res. 37: 1845-1851.
100. Williams, G. M. (1980) The pathogenesis of rat liver cancer caused by chemical carcinogens. Biochim. Biophys. Acta 605: 167-189.
101. Williams, G. M. and Furuya, K. (1984) Distinction between liver neoplasm promoting and syncarcinogenic effects demonstrated by exposure to phenobarbital or diethylnitrosamine either before or after N-2-fluorenylacetamide. Carcinogenesis 5: 171-174.
102. Williams, G. M., Tanaka, T., Maruyama, H., Maeura, Y., Weisburger, J. H. and Zang, E. (1991) Modulation by butylated hydroxytoluene of liver and bladder carcinogenesis induced by chronic low level exposure to 2-acetylaminofluorene. Cancer Res. 51: 6224-6230.
103. Wilpart, M. and Roberfroid, M. (1986) Effects of secondary biliary acids on the mutagenicity of N-methyl-N-nitro-N-nitrosoguanidine, 2-acetylaminofluorene and 2-nitrofluorene towards Salmonella typhimurium strains. Carcinogenesis 5: 703-706.
104. Wilson, R. H., DeEds, F. and Cox, A. J., Jr. (1941) The toxicity and carcinogenic activity of 2-acetaminofluorene. Cancer Res. 1: 595-608.
105. 1 mouse. Proc. Natl. Acad. Sci. USA 83: 5825-5829.
106. Wolff, G. L., Gaylor, D. W., Blackwell, B. N. and Moore, G. E. (1991) Bladder and liver tumorigenesis induced by 2-acetylaminofluorene in different F mouse hybrids: variation with genotypes and effects of using more than one genotype on risk assessment. J. Toxicol. Environ. Health 33: 327-348.
107. Yamamoto, N., Anderson, M. D. and DiPaolo, J. A. (1974) Phage and bacterial inactivation and prophage induction by chemical carcinogens. Mol. Pharmacol. 10: 640-647.